SIGNUM has substantial experience advising international pharmaceutical companies, medical device manufacturers and distributors and other healthcare sector participants on their operations in Kazakhstan.
We support clients on a broad range of matters relating to pharmaceuticals and medical devices – from market entry, corporate structuring and M&A transactions to importation, distribution, storage, advertising and promotion of products. Our team also advises on medical device certification, commercial arrangements, intellectual property, personal data and interactions with healthcare and pharmaceutical professionals.
Compliance and anti-corruption are particularly important in the pharmaceutical sector. SIGNUM advises international companies on corporate policies, interactions with government institutions and healthcare organisations, product promotion and other matters requiring an understanding of both industry-specific regulation and international business ethics standards.
Our experience includes cross-border transactions involving pharmaceutical assets, medical device and public-private partnership projects and ongoing legal support to international companies on matters arising from their Kazakhstan operations.
Advised a major Japanese pharmaceutical company on intellectual property matters, including the review and negotiation of a sublicence agreement.
Reviewed a licence agreement, lease agreement, pharmaceutical products distribution agreement and shareholders’ agreement for a major international pharmaceutical company for compliance with Kazakhstan law.
Drafted and reviewed licence agreements and prepared legal memoranda on Kazakhstan law requirements applicable to licensing and franchising arrangements.
Advised pharmaceutical companies on contractual arrangements relating to the distribution, sale and promotion of pharmaceutical products and medical devices.
Advised the world’s largest medical device company on the implementation of a public-private partnership project for the development and equipping of angiography laboratories in the Kyzylorda region.
Advised a foreign pharmaceutical company on an investment transaction involving its admission as a participant in a Kazakhstan LLP through an increase of the charter capital, including corporate implementation and state re-registration.
Advised a leading Danish medical equipment distributor on corporate and regulatory matters relating to its cross-border acquisition of a pharmaceutical company in Kazakhstan.
Advised international pharmaceutical and medical companies on establishing and conducting business in Kazakhstan and ongoing corporate matters.
Advised a leading Danish medical equipment distributor on the cross-border acquisition of a pharmaceutical company in Kazakhstan.
Conducted legal due diligence of a pharmaceutical asset as part of a complex multi-jurisdictional M&A transaction, acting as Kazakhstan counsel to a major international law firm.
Advised on corporate, regulatory and transactional matters relating to acquisitions of pharmaceutical businesses and assets in Kazakhstan.
Advised the world’s largest medical device company on Kazakhstan certification requirements applicable to its products.
Advised a major pharmaceutical company on legal requirements applicable to the advertising of pharmaceutical products.
Prepared a legal opinion on statutory requirements governing the distribution of pharmaceutical product samples.
Prepared a legal opinion on advertising of over-the-counter pharmaceutical products in hospitals and pharmacies.
Prepared a legal memorandum on pharmaceutical storage requirements and the display of pharmaceutical products at retail premises.
Advised international pharmaceutical companies on personal data protection and requirements governing the collection, use and storage of personal data.
Prepared a legal opinion for a major pharmaceutical company on the storage and processing of personal data relating to doctors and pharmacy employees using the company’s information systems and data storage facilities.
Prepared internal documentation for an international pharmaceutical company, including personal data protection policies and policies governing interactions with medical and pharmaceutical professionals.
Advised one of the largest South Korean pharmaceutical companies on anti-bribery and compliance policies and procedures.
Prepared a legal opinion for an international pharmaceutical company on interactions with representatives of government institutions, hospitals and other organisations from an anti-corruption law perspective.
Advised pharmaceutical companies on interactions with medical and pharmaceutical professionals, including business ethics and anti-corruption requirements.
Developed internal compliance documentation and policies governing interactions between pharmaceutical company employees and healthcare professionals and other market participants.